The role of Astakine in Scylla paramamosain against Vibrio alginolyticus and white spot syndrome virus infection.
Animals
Apoptosis
Arthropod Proteins
/ genetics
Brachyura
/ immunology
Cell Proliferation
Disease Resistance
/ genetics
Gene Expression Regulation
/ immunology
Hemocytes
/ metabolism
Immunity, Humoral
Survival Rate
Tissue Distribution
Vascular Endothelial Growth Factor, Endocrine-Gland-Derived
/ genetics
Vibrio alginolyticus
/ physiology
Virus Replication
White spot syndrome virus 1
/ physiology
Astakine
Hemocytes
Immunization
Scylla paramamosain
Vibrio alginolyticus
White spot syndrome virus
Journal
Fish & shellfish immunology
ISSN: 1095-9947
Titre abrégé: Fish Shellfish Immunol
Pays: England
ID NLM: 9505220
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
01
11
2019
revised:
09
01
2020
accepted:
13
01
2020
pubmed:
19
1
2020
medline:
21
11
2020
entrez:
19
1
2020
Statut:
ppublish
Résumé
Astakine is a crucial factor in the proliferation and differentiation of hematopoietic stem cells and is directly involved in hematopoiesis in crustaceans. To assess the role of Astakine in the innate immune system of Scylla paramamosain, the immune responses in healthy and Astakine-inhibited S. paramamosain were investigated in the present study. The RNA transcripts of Astakine were widely distributed in all examined tissues, with significantly higher levels of expression in hemocytes of both healthy and challenged S. paramamosain with Vibrio alginolyticus and WSSV. When Astakine was knocked down by RNA interference technology, immune-related genes, including Janus kinase, prophenoloxidase, hemocyanin, β-actin, myosin II essential light chain-like protein, signal transducer and activator of transcription, Relish, and C-type-lectin, were significantly down-regulated in hemocytes. The levels of phenoloxidaseactivity (PO), total hemocyte counts (THC) and hemocyte proliferation decreased significantly in hemocytes of Astakine-dsRNA treated S. paramamosain. After being challenged with V. alginolyticus and WSSV, the THC decreased significantly and the levels of hemocyte apoptosis increased significantly in Astakine-dsRNA treated S. paramamosain in comparison with those in infected groups without Astakine-dsRNA treatment. After being challenged with WSSV, the WSSV copies were significantly lower in Astakine-dsRNA treated groups than those in the WSSV infection group, which suggested that knockdown of Astakine was not conductive to WSSV replication and this might be associated with the decreasing THC. The results of survival analysis showed that the survival rate of V. alginolyticus or WSSV infected S. paramamosain decreased significantly following Astakine knockdown. These results suggested that RNA interference of Astakine might weaken the resistance of S. paramamosain to V. alginolyticus or WSSV infection. The weaken resistivity after knockdown Astakine might be related to the changes of important immune-related gene expression, THC, PO activity, proliferation and apoptosis of hemocytes.
Identifiants
pubmed: 31953197
pii: S1050-4648(20)30024-3
doi: 10.1016/j.fsi.2020.01.024
pii:
doi:
Substances chimiques
Arthropod Proteins
0
Vascular Endothelial Growth Factor, Endocrine-Gland-Derived
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
236-244Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.